Food News and Research

RSS

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.

27 Jan 2014

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.

27 Jan 2014

Study provides evidence of link between food selection and self-perceived guilt or innocence

Can last meals reveal more about individuals on death row than their taste preference? Some have argued there is significance embedded in death row last meal decisions.

27 Jan 2014

Most high-risk CV devices approved without clinical data

Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.

From Medtronic 27 Jan 2014

Cantrell Drug Company amends FDA registration to include 503B compounding outsourcing facility

Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B "compounding outsourcing facility" designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.

25 Jan 2014

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to have their aortic valves replaced trough traditional open-heart surgery.

25 Jan 2014

Beverly Hills Physicians offer free informational seminars to adults interested in surgical weight loss

Many of the patients seen by the board-certified bariatric surgeons at Beverly Hills Physicians come to an initial consultation feeling as though they've reached the end of their rope trying to lose weight.

25 Jan 2014

Study shows impulsive personalities more likely to report higher levels of food addiction

The same kinds of impulsive behavior that lead some people to abuse alcohol and other drugs may also be an important contributor to an unhealthy relationship with food, according to new research from the University of Georgia.

25 Jan 2014

Researchers develop novel instruments and software for inspecting food microstructure

Applying imaging techniques to food structure is helping scientists devise ways of improving the quality of processed food. Food's microstructure can explain many of its characteristics—be it cake's sponginess, bread's crispness, cracker's crunchiness or fruits' inner gas and water transport system and even colour. Understanding such microstructure and how it changes during food processing is essential to produce high-quality food.

25 Jan 2014

FDA to make recommendations on safety of oral tablets used to treat ragweed allergy symptoms

There is more to seasonal allergies than a little congestion and sneezing. If you notice eating watermelon, cantaloupe or avocado make you cough and itch, it may be a symptom of ragweed allergy. But more help might be on the way for some of the 23 million hay fever sufferers.

24 Jan 2014

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

TherapeuticsMD, Inc., a women's healthcare company, announced today that it has initiated the SPRY Trial, a randomized, placebo-controlled phase 3 clinical trial designed to evaluate the safety and efficacy of TX 12-002-HR, its oral progesterone candidate for secondary amenorrhea, a condition treated to maintain fertility in young premenopausal women.

24 Jan 2014

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.

24 Jan 2014

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.

24 Jan 2014

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.

24 Jan 2014

Environmental endocrine disrupters may endanger embryonic heart valves

Exposure to environmental endocrine disrupters, such as bisphenol A, which mimic estrogen, is associated with adverse health effects. Bisphenol A is commonly found in plastic bottles and plastic food containers. New research from a team including Carnegie's Daniel Gorelick and Marnie Halpern on the effects of these chemicals on zebrafish shows that embryonic heart valves could be particularly in danger. It is published by Environmental Health Perspectives.

24 Jan 2014

Top-notch leaders to discuss link between fruit and vegetable production, medical advances

People interested in healthy foods are invited to a day-long conference Feb. 25 in College Station to hear the latest findings on connections between fruit and vegetable production and medical advances.

24 Jan 2014

Expects develop web-based platform for Canadians to take personal ownership of their health

The recent report by the Health Council of Canada puts Canada in last place among OECD countries for healthcare wait times with major concerns regarding access to care. With only 31 per cent of Canadians getting a same-day or next-day doctor's appointment and 15 per cent of Canadians without a family doctor, Canada's strained healthcare system has reached a breaking point.

24 Jan 2014

Turning point in Americans' dietary and health behavior

All those people who've been telling us for years that we should eat more healthy foods and cut our calories - stop, take a moment, and celebrate

24 Jan 2014

Study: 94% of people say individuals are primarily to blame for rise in obesity

Fast food restaurants take a lot of heat for the rise in obesity in the United States, but is it really their fault? A research survey conducted by two food economists revealed that most people believe individuals are to blame for their own obesity - not restaurants, grocery stores, farmers, or government policies. One implication from this research is that creating and enforcing public policies to help reduce obesity and/or encourage healthier food choices may not be as effective as policy makers would like.

24 Jan 2014

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week.

From Medtronic 24 Jan 2014

Food News and Research

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

NextSource BioTechnology announces product re-launch, market availability of Lomustine in U.S.

Study provides evidence of link between food selection and self-perceived guilt or innocence

Most high-risk CV devices approved without clinical data

Cantrell Drug Company amends FDA registration to include 503B compounding outsourcing facility

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

Beverly Hills Physicians offer free informational seminars to adults interested in surgical weight loss

Study shows impulsive personalities more likely to report higher levels of food addiction

Researchers develop novel instruments and software for inspecting food microstructure

FDA to make recommendations on safety of oral tablets used to treat ragweed allergy symptoms

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

Environmental endocrine disrupters may endanger embryonic heart valves

Top-notch leaders to discuss link between fruit and vegetable production, medical advances

Expects develop web-based platform for Canadians to take personal ownership of their health

Turning point in Americans' dietary and health behavior

Study: 94% of people say individuals are primarily to blame for rise in obesity

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Understanding cultivated meat and its global potential eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News